drugset
drugset / Trial / NCT00961831

Radiation Dosimetry, Metabolism, Safety, Tolerability and Positron Emission Tomography/Computed Tomography (PET/CT) Imaging With BAY 85-8050 in Healthy Volunteers and Patients

NCT00961831 ↗

Phase 1 Completed 20 enrolled Bayer
Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

This study is a visual assessment of diagnostic PET/CT images obtained after a single intravenous injection of BAY85-8050 in patients with cancer

Timeline

Start
2009-04-15
Primary completion
2009-12-16
Completion
2009-12-16

Drugs

EvaluationDrugModalityDoseRoute
Subject BAY85-8050 Unknown — Intravenous

Indications

neoplasm